Jakob Egle is a counsel in the London office of Gibson, Dunn & Crutcher. Mr. Egle is a member of the Private Equity, Mergers and Acquisitions and Corporate Practice Groups.

Mr. Egle regularly advises on a wide range of private equity, corporate, and M&A transactions in Europe, with a particular focus on leveraged buyouts, growth capital investments, divestitures, joint ventures, shareholder arrangements and management equity plans.

Before joining Gibson Dunn, Mr. Egle was an associate in the private equity practice of another international law firm and spent time on secondment at The Blackstone Group and Goldman Sachs International.

Selected experience:*

• KKR on its majority acquisition of Biosynth Carbosynth, a Swiss life sciences reagents and custom synthesis and manufacturing services company.
• KKR on its initial investment and follow-on investment in KnowBe4, a security awareness training and simulated phishing platform provider, with participation from TenEleven Ventures.
• KKR on its investment in Feedzai, a leading cloud-based financial risk management platform.
• KKR on its investment in Nordic Bioscience, a Danish biomarker development company.
• Blackstone on its €2.2 billion acquisition of Cirsa Gaming Corporation SA, a Spanish gambling operator active across Spain, Italy and Latin America.
• Goldman Sachs Private Capital on its investments in DocPlanner Group, an international healthcare booking platform provider.
• KKR on its acquisition of Argenta, a leading animal pharmaceutical research and manufacturing company.

*Some of these representations occurred prior to Mr. Egle’s association with Gibson Dunn.